ENDOCRINE-RELATED CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2194693, encodeId=add421946937b, content=偏重的研究方向：甲状腺肿瘤 经验分享：中了一篇，两个审稿人，审稿时间大约3月，修回后1月内接收。编辑和审稿人都很负责，邮件询问也都有所回复。整体流程大约4-5月，着急的同道可以暂不考虑，年收文量较少，现在可选oa模式，英镑最划算，约28000rmb，1月内收到first proof，接收后第2-3期发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Fri Mar 22 14:39:09 CST 2024, time=2024-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124670, encodeId=018f21246e0bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Sun Apr 09 23:20:25 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115305, encodeId=174f211530524, content=请问一下这个杂志接受生信+实验的文章嘛，需要提供原始数据和WB整膜嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e15211770, createdName=1475fbf4m67暂无昵称, createdTime=Sat Feb 18 20:13:15 CST 2023, time=2023-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090011, encodeId=c2ad10900116c, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090012, encodeId=f6141090012ec, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069204, encodeId=c13b106920410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：ENDOCR-RELAT CANCER杂志属于内分泌与代谢领域的顶尖期刊，投稿难度很大，文章质量很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b651641203, createdName=熊, createdTime=Thu Nov 11 09:45:35 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566547, encodeId=101556654e8a, content=我也秒拒，可能对中国人不友好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e01696713, createdName=ashleyjr, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565238, encodeId=291b565238ae, content=会给建议吗？为啥秒拒啊csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0da1619050, createdName=12341234a, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559296, encodeId=3dc45592962e, content=多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Tue Jul 17 00:00:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555758, encodeId=9f09555e586f, content=投稿命中率:5.0 经验分享：想要被秒拒的感觉就来这里试一下吧，O(∩_∩)O哈哈~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sun May 06 08:19:00 CST 2018, time=2018-05-06, status=1, ipAttribution=)]

2024-03-22 发大文章带我一个二十作吧来自上海

偏重的研究方向：甲状腺肿瘤
经验分享：中了一篇，两个审稿人，审稿时间大约3月，修回后1月内接收。编辑和审稿人都很负责，邮件询问也都有所回复。整体流程大约4-5月，着急的同道可以暂不考虑，年收文量较少，现在可选oa模式，英镑最划算，约28000rmb，1月内收到first proof，接收后第2-3期发表

79 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194693, encodeId=add421946937b, content=偏重的研究方向：甲状腺肿瘤 经验分享：中了一篇，两个审稿人，审稿时间大约3月，修回后1月内接收。编辑和审稿人都很负责，邮件询问也都有所回复。整体流程大约4-5月，着急的同道可以暂不考虑，年收文量较少，现在可选oa模式，英镑最划算，约28000rmb，1月内收到first proof，接收后第2-3期发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Fri Mar 22 14:39:09 CST 2024, time=2024-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124670, encodeId=018f21246e0bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Sun Apr 09 23:20:25 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115305, encodeId=174f211530524, content=请问一下这个杂志接受生信+实验的文章嘛，需要提供原始数据和WB整膜嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e15211770, createdName=1475fbf4m67暂无昵称, createdTime=Sat Feb 18 20:13:15 CST 2023, time=2023-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090011, encodeId=c2ad10900116c, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090012, encodeId=f6141090012ec, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069204, encodeId=c13b106920410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：ENDOCR-RELAT CANCER杂志属于内分泌与代谢领域的顶尖期刊，投稿难度很大，文章质量很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b651641203, createdName=熊, createdTime=Thu Nov 11 09:45:35 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566547, encodeId=101556654e8a, content=我也秒拒，可能对中国人不友好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e01696713, createdName=ashleyjr, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565238, encodeId=291b565238ae, content=会给建议吗？为啥秒拒啊csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0da1619050, createdName=12341234a, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559296, encodeId=3dc45592962e, content=多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Tue Jul 17 00:00:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555758, encodeId=9f09555e586f, content=投稿命中率:5.0 经验分享：想要被秒拒的感觉就来这里试一下吧，O(∩_∩)O哈哈~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sun May 06 08:19:00 CST 2018, time=2018-05-06, status=1, ipAttribution=)]

2023-04-09 ms8000000563552859 来自江苏省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：生信
经验分享：无

62 0

[GetPortalCommentsPageByObjectIdResponse(id=2194693, encodeId=add421946937b, content=偏重的研究方向：甲状腺肿瘤 经验分享：中了一篇，两个审稿人，审稿时间大约3月，修回后1月内接收。编辑和审稿人都很负责，邮件询问也都有所回复。整体流程大约4-5月，着急的同道可以暂不考虑，年收文量较少，现在可选oa模式，英镑最划算，约28000rmb，1月内收到first proof，接收后第2-3期发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Fri Mar 22 14:39:09 CST 2024, time=2024-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124670, encodeId=018f21246e0bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Sun Apr 09 23:20:25 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115305, encodeId=174f211530524, content=请问一下这个杂志接受生信+实验的文章嘛，需要提供原始数据和WB整膜嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e15211770, createdName=1475fbf4m67暂无昵称, createdTime=Sat Feb 18 20:13:15 CST 2023, time=2023-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090011, encodeId=c2ad10900116c, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090012, encodeId=f6141090012ec, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069204, encodeId=c13b106920410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：ENDOCR-RELAT CANCER杂志属于内分泌与代谢领域的顶尖期刊，投稿难度很大，文章质量很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b651641203, createdName=熊, createdTime=Thu Nov 11 09:45:35 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566547, encodeId=101556654e8a, content=我也秒拒，可能对中国人不友好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e01696713, createdName=ashleyjr, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565238, encodeId=291b565238ae, content=会给建议吗？为啥秒拒啊csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0da1619050, createdName=12341234a, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559296, encodeId=3dc45592962e, content=多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Tue Jul 17 00:00:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555758, encodeId=9f09555e586f, content=投稿命中率:5.0 经验分享：想要被秒拒的感觉就来这里试一下吧，O(∩_∩)O哈哈~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sun May 06 08:19:00 CST 2018, time=2018-05-06, status=1, ipAttribution=)]

2023-02-18 1475fbf4m67暂无昵称来自上海

请问一下这个杂志接受生信+实验的文章嘛，需要提供原始数据和WB整膜嘛

81 0

[GetPortalCommentsPageByObjectIdResponse(id=2194693, encodeId=add421946937b, content=偏重的研究方向：甲状腺肿瘤 经验分享：中了一篇，两个审稿人，审稿时间大约3月，修回后1月内接收。编辑和审稿人都很负责，邮件询问也都有所回复。整体流程大约4-5月，着急的同道可以暂不考虑，年收文量较少，现在可选oa模式，英镑最划算，约28000rmb，1月内收到first proof，接收后第2-3期发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Fri Mar 22 14:39:09 CST 2024, time=2024-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124670, encodeId=018f21246e0bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Sun Apr 09 23:20:25 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115305, encodeId=174f211530524, content=请问一下这个杂志接受生信+实验的文章嘛，需要提供原始数据和WB整膜嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e15211770, createdName=1475fbf4m67暂无昵称, createdTime=Sat Feb 18 20:13:15 CST 2023, time=2023-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090011, encodeId=c2ad10900116c, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090012, encodeId=f6141090012ec, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069204, encodeId=c13b106920410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：ENDOCR-RELAT CANCER杂志属于内分泌与代谢领域的顶尖期刊，投稿难度很大，文章质量很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b651641203, createdName=熊, createdTime=Thu Nov 11 09:45:35 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566547, encodeId=101556654e8a, content=我也秒拒，可能对中国人不友好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e01696713, createdName=ashleyjr, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565238, encodeId=291b565238ae, content=会给建议吗？为啥秒拒啊csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0da1619050, createdName=12341234a, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559296, encodeId=3dc45592962e, content=多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Tue Jul 17 00:00:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555758, encodeId=9f09555e586f, content=投稿命中率:5.0 经验分享：想要被秒拒的感觉就来这里试一下吧，O(∩_∩)O哈哈~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sun May 06 08:19:00 CST 2018, time=2018-05-06, status=1, ipAttribution=)]

2021-12-29 Mia

期刊发送的信件里需要注意几个方面的内容？

93 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194693, encodeId=add421946937b, content=偏重的研究方向：甲状腺肿瘤 经验分享：中了一篇，两个审稿人，审稿时间大约3月，修回后1月内接收。编辑和审稿人都很负责，邮件询问也都有所回复。整体流程大约4-5月，着急的同道可以暂不考虑，年收文量较少，现在可选oa模式，英镑最划算，约28000rmb，1月内收到first proof，接收后第2-3期发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Fri Mar 22 14:39:09 CST 2024, time=2024-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124670, encodeId=018f21246e0bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Sun Apr 09 23:20:25 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115305, encodeId=174f211530524, content=请问一下这个杂志接受生信+实验的文章嘛，需要提供原始数据和WB整膜嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e15211770, createdName=1475fbf4m67暂无昵称, createdTime=Sat Feb 18 20:13:15 CST 2023, time=2023-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090011, encodeId=c2ad10900116c, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090012, encodeId=f6141090012ec, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069204, encodeId=c13b106920410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：ENDOCR-RELAT CANCER杂志属于内分泌与代谢领域的顶尖期刊，投稿难度很大，文章质量很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b651641203, createdName=熊, createdTime=Thu Nov 11 09:45:35 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566547, encodeId=101556654e8a, content=我也秒拒，可能对中国人不友好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e01696713, createdName=ashleyjr, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565238, encodeId=291b565238ae, content=会给建议吗？为啥秒拒啊csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0da1619050, createdName=12341234a, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559296, encodeId=3dc45592962e, content=多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Tue Jul 17 00:00:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555758, encodeId=9f09555e586f, content=投稿命中率:5.0 经验分享：想要被秒拒的感觉就来这里试一下吧，O(∩_∩)O哈哈~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sun May 06 08:19:00 CST 2018, time=2018-05-06, status=1, ipAttribution=)]

2021-12-27 Gym璨烨

什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？

73 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194693, encodeId=add421946937b, content=偏重的研究方向：甲状腺肿瘤 经验分享：中了一篇，两个审稿人，审稿时间大约3月，修回后1月内接收。编辑和审稿人都很负责，邮件询问也都有所回复。整体流程大约4-5月，着急的同道可以暂不考虑，年收文量较少，现在可选oa模式，英镑最划算，约28000rmb，1月内收到first proof，接收后第2-3期发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Fri Mar 22 14:39:09 CST 2024, time=2024-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124670, encodeId=018f21246e0bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Sun Apr 09 23:20:25 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115305, encodeId=174f211530524, content=请问一下这个杂志接受生信+实验的文章嘛，需要提供原始数据和WB整膜嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e15211770, createdName=1475fbf4m67暂无昵称, createdTime=Sat Feb 18 20:13:15 CST 2023, time=2023-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090011, encodeId=c2ad10900116c, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090012, encodeId=f6141090012ec, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069204, encodeId=c13b106920410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：ENDOCR-RELAT CANCER杂志属于内分泌与代谢领域的顶尖期刊，投稿难度很大，文章质量很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b651641203, createdName=熊, createdTime=Thu Nov 11 09:45:35 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566547, encodeId=101556654e8a, content=我也秒拒，可能对中国人不友好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e01696713, createdName=ashleyjr, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565238, encodeId=291b565238ae, content=会给建议吗？为啥秒拒啊csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0da1619050, createdName=12341234a, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559296, encodeId=3dc45592962e, content=多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Tue Jul 17 00:00:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555758, encodeId=9f09555e586f, content=投稿命中率:5.0 经验分享：想要被秒拒的感觉就来这里试一下吧，O(∩_∩)O哈哈~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sun May 06 08:19:00 CST 2018, time=2018-05-06, status=1, ipAttribution=)]

2021-11-11 熊

审稿速度:2.0 | 投稿命中率:25.0
经验分享：ENDOCR-RELAT CANCER杂志属于内分泌与代谢领域的顶尖期刊，投稿难度很大，文章质量很高。

86 0

[GetPortalCommentsPageByObjectIdResponse(id=2194693, encodeId=add421946937b, content=偏重的研究方向：甲状腺肿瘤 经验分享：中了一篇，两个审稿人，审稿时间大约3月，修回后1月内接收。编辑和审稿人都很负责，邮件询问也都有所回复。整体流程大约4-5月，着急的同道可以暂不考虑，年收文量较少，现在可选oa模式，英镑最划算，约28000rmb，1月内收到first proof，接收后第2-3期发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Fri Mar 22 14:39:09 CST 2024, time=2024-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124670, encodeId=018f21246e0bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Sun Apr 09 23:20:25 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115305, encodeId=174f211530524, content=请问一下这个杂志接受生信+实验的文章嘛，需要提供原始数据和WB整膜嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e15211770, createdName=1475fbf4m67暂无昵称, createdTime=Sat Feb 18 20:13:15 CST 2023, time=2023-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090011, encodeId=c2ad10900116c, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090012, encodeId=f6141090012ec, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069204, encodeId=c13b106920410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：ENDOCR-RELAT CANCER杂志属于内分泌与代谢领域的顶尖期刊，投稿难度很大，文章质量很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b651641203, createdName=熊, createdTime=Thu Nov 11 09:45:35 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566547, encodeId=101556654e8a, content=我也秒拒，可能对中国人不友好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e01696713, createdName=ashleyjr, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565238, encodeId=291b565238ae, content=会给建议吗？为啥秒拒啊csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0da1619050, createdName=12341234a, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559296, encodeId=3dc45592962e, content=多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Tue Jul 17 00:00:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555758, encodeId=9f09555e586f, content=投稿命中率:5.0 经验分享：想要被秒拒的感觉就来这里试一下吧，O(∩_∩)O哈哈~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sun May 06 08:19:00 CST 2018, time=2018-05-06, status=1, ipAttribution=)]

2019-02-07 ashleyjr

我也秒拒，可能对中国人不友好吧

241 0

[GetPortalCommentsPageByObjectIdResponse(id=2194693, encodeId=add421946937b, content=偏重的研究方向：甲状腺肿瘤 经验分享：中了一篇，两个审稿人，审稿时间大约3月，修回后1月内接收。编辑和审稿人都很负责，邮件询问也都有所回复。整体流程大约4-5月，着急的同道可以暂不考虑，年收文量较少，现在可选oa模式，英镑最划算，约28000rmb，1月内收到first proof，接收后第2-3期发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Fri Mar 22 14:39:09 CST 2024, time=2024-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124670, encodeId=018f21246e0bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Sun Apr 09 23:20:25 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115305, encodeId=174f211530524, content=请问一下这个杂志接受生信+实验的文章嘛，需要提供原始数据和WB整膜嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e15211770, createdName=1475fbf4m67暂无昵称, createdTime=Sat Feb 18 20:13:15 CST 2023, time=2023-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090011, encodeId=c2ad10900116c, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090012, encodeId=f6141090012ec, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069204, encodeId=c13b106920410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：ENDOCR-RELAT CANCER杂志属于内分泌与代谢领域的顶尖期刊，投稿难度很大，文章质量很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b651641203, createdName=熊, createdTime=Thu Nov 11 09:45:35 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566547, encodeId=101556654e8a, content=我也秒拒，可能对中国人不友好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e01696713, createdName=ashleyjr, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565238, encodeId=291b565238ae, content=会给建议吗？为啥秒拒啊csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0da1619050, createdName=12341234a, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559296, encodeId=3dc45592962e, content=多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Tue Jul 17 00:00:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555758, encodeId=9f09555e586f, content=投稿命中率:5.0 经验分享：想要被秒拒的感觉就来这里试一下吧，O(∩_∩)O哈哈~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sun May 06 08:19:00 CST 2018, time=2018-05-06, status=1, ipAttribution=)]

2019-01-06 12341234a

会给建议吗？为啥秒拒啊csqzsm 2018-07-17 00:00:00 发表:
多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈

csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈

235 0

[GetPortalCommentsPageByObjectIdResponse(id=2194693, encodeId=add421946937b, content=偏重的研究方向：甲状腺肿瘤 经验分享：中了一篇，两个审稿人，审稿时间大约3月，修回后1月内接收。编辑和审稿人都很负责，邮件询问也都有所回复。整体流程大约4-5月，着急的同道可以暂不考虑，年收文量较少，现在可选oa模式，英镑最划算，约28000rmb，1月内收到first proof，接收后第2-3期发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Fri Mar 22 14:39:09 CST 2024, time=2024-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124670, encodeId=018f21246e0bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Sun Apr 09 23:20:25 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115305, encodeId=174f211530524, content=请问一下这个杂志接受生信+实验的文章嘛，需要提供原始数据和WB整膜嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e15211770, createdName=1475fbf4m67暂无昵称, createdTime=Sat Feb 18 20:13:15 CST 2023, time=2023-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090011, encodeId=c2ad10900116c, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090012, encodeId=f6141090012ec, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069204, encodeId=c13b106920410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：ENDOCR-RELAT CANCER杂志属于内分泌与代谢领域的顶尖期刊，投稿难度很大，文章质量很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b651641203, createdName=熊, createdTime=Thu Nov 11 09:45:35 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566547, encodeId=101556654e8a, content=我也秒拒，可能对中国人不友好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e01696713, createdName=ashleyjr, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565238, encodeId=291b565238ae, content=会给建议吗？为啥秒拒啊csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0da1619050, createdName=12341234a, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559296, encodeId=3dc45592962e, content=多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Tue Jul 17 00:00:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555758, encodeId=9f09555e586f, content=投稿命中率:5.0 经验分享：想要被秒拒的感觉就来这里试一下吧，O(∩_∩)O哈哈~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sun May 06 08:19:00 CST 2018, time=2018-05-06, status=1, ipAttribution=)]

2018-07-17 csqzsm

多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈

274 0

[GetPortalCommentsPageByObjectIdResponse(id=2194693, encodeId=add421946937b, content=偏重的研究方向：甲状腺肿瘤 经验分享：中了一篇，两个审稿人，审稿时间大约3月，修回后1月内接收。编辑和审稿人都很负责，邮件询问也都有所回复。整体流程大约4-5月，着急的同道可以暂不考虑，年收文量较少，现在可选oa模式，英镑最划算，约28000rmb，1月内收到first proof，接收后第2-3期发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Fri Mar 22 14:39:09 CST 2024, time=2024-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124670, encodeId=018f21246e0bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：生信 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Sun Apr 09 23:20:25 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115305, encodeId=174f211530524, content=请问一下这个杂志接受生信+实验的文章嘛，需要提供原始数据和WB整膜嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e15211770, createdName=1475fbf4m67暂无昵称, createdTime=Sat Feb 18 20:13:15 CST 2023, time=2023-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1090011, encodeId=c2ad10900116c, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090012, encodeId=f6141090012ec, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069204, encodeId=c13b106920410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：ENDOCR-RELAT CANCER杂志属于内分泌与代谢领域的顶尖期刊，投稿难度很大，文章质量很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b651641203, createdName=熊, createdTime=Thu Nov 11 09:45:35 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566547, encodeId=101556654e8a, content=我也秒拒，可能对中国人不友好吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1e01696713, createdName=ashleyjr, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565238, encodeId=291b565238ae, content=会给建议吗？为啥秒拒啊csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=csqzsm 2018-07-17 00:00:00 发表: 多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0da1619050, createdName=12341234a, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559296, encodeId=3dc45592962e, content=多少秒发表想要被秒拒的感觉就来这里试一下吧哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Tue Jul 17 00:00:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555758, encodeId=9f09555e586f, content=投稿命中率:5.0 经验分享：想要被秒拒的感觉就来这里试一下吧，O(∩_∩)O哈哈~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Sun May 06 08:19:00 CST 2018, time=2018-05-06, status=1, ipAttribution=)]

2018-05-06 futuremaster

投稿命中率:5.0
经验分享：想要被秒拒的感觉就来这里试一下吧，O(∩_∩)O哈哈~

302 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务